Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 79, Issue 1, 1994, Pages 205-210

  Morrow, Linda A ^b,c   O’brien, Maureen B ^a   Moller, David E ^a   Flier, Jeffrey S ^a   Moses, Alan C ^a  

^a Charles A Dana Research Institute   (United States)

^b Divisions of Gerontology   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HUMAN INSULIN; INSULIN; OCTREOTIDE; RECOMBINANT SOMATOMEDIN C; SUSTACAL;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; KINETICS; RECOMBINANT PROTEINS; SYNDROME;

EID: 0028300538     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.79.1.8027228     Document Type: Article

References (24)

1. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER. 1991 Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia. 34:675-679.
2. Usala α L, Madigan I, Burguera B, et al. 1992 Brief report: treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes. N Engl J Med. 327:853-857.
3. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, Mac-Cuish AC. 1990 Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome [Letter]. N Engl J Med. 323:1425-1426.
4. Flier JS. 1992 Lilly Lecture: syndromes of insulin resistance. From patient to gene and back again. Diabetes. 41:1207-1219.
5. Kahn CR, Flier JS, Bar RS, et al. 1976 The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med. 294:739-745.
6. O'Rahilly S, Choi WH, Patel P, Turner RC, Flier JS, Möller DE. 1991 Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes. 40:777-782.
7. Möller DE, Cohen O, Yamaguchi Y, Azziz R, Eberle A, Flier JS. 1993 Prevalence of insulin receptor mutations in insulin-resistant women with ovarian hyperandrogenism and acanthosis nigricans [Abstract]. Clin Res. 4L274A.
8. Lieberman SA, Bukar J, Chen SA, et al. 1992 Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycémie response in humans. J Clin Endocrinol Metab. 75:30-36.
9. American Diabetes Association. 1988 Physician's guide to noninsulin-dependent (type II) diabetes. Diagnosis and treatment. Alexandria: American Diabetes Association. Moller DE, Flier JS. 1991 Insulin resistance-mechanisms, syndromes and implications. N Engl J Med. 325:938-948.
10. Taylor SI. 1992 Molecular mechanisms of insulin resistance: lessons from patients with mutations in the insulin receptor gene. Diabetes. 41:1473-1490.
11. Scarlet JA, Kolterman OG, Moore P, et al. 1982 Insulin resistance and diabetes due to a genetic defect in insulin receptors. J Clin Endocrinol Metab. 55:123-1232.
12. Taylor SI, Kadowaki T, Kadowaki H, Accili D, Cama A, McKeon C. 1990 Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care. 13:257-279.
13. O'Rahilly S, Moller DE. 1992 Mutant insulin receptors in syndromes of insulin resistance. Clin Endocrinol (Oxf). 36:121-132.
14. Moller DE, Yokota A, White MF, Pazianos AG, Flier JS. 1990 A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. J Biol Chem. 265:14979-14985.
15. Moller DE, Flier JS. 1988 Detection of an alteration in the insulin receptor gene in a patient with insulin resistance, acanthosis nigricans, and polycystic ovary syndrome (type A insulin resistance). N Engl J Med. 319:1526-1529.
16. Kuzuya H, Matsuura N, Sakamoto M, et al. 1993 Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes. 42:696-705.
17. Vuorinen-Markkola H, Koivisto VA, Yki-Jarvinen H. 1992 Mechanisms of hyperglycemiαinduced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes. 41:571-580.
18. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. 1993 Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care. 16:21-31.
19. Sharp PS, Mohan V, Vitelli F, Maneschi F, Kohner EM. 1987 Changes in insulin resistance with long-term insulin therapy. Diabetes Care. 10:56-61.
20. Baron AD, Laakso M, Brechtel G, Edelman SV. 1991 Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. J Clin Invest. 87:1186-1194.
21. Zenobi PD, Jaeggi-Groisman SE, Riesen WF, Roder ME, Froesch ER. 1992 Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest. 90:2234-2241.
22. Rossetti L, Giaccari A, DeFronzo RA. 1990 Glucose toxicity. Diabetes Care. 13:610-630.
23. Barbiéri RL, Smith S, Ryan KJ. 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 50:197-212.
24. Jabri N, Schalch DS, Schwartz SL, et al. 1994 Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes. 43:369-374.